Try GOLD - Free
Foxconn to ramp up local component mfg in India
Mint New Delhi
|October 15, 2025
The Taiwanese contract manufacturer has committed $11.5 bn to India over the past decade
Foxconn is also looking to make more components for other companies, including Google's Pixel smartphones.
(BLOOMBERG)
Foxconnis looking to manufacture more electronic components in Tamil Nadu to improve its profitability after the Taiwanese contract manufacturer reaffirmed that it will continue with its planned investment of $1.5 billion, according to three people directly aware of the plans.
Foxconn, which assembles iPhones for Apple, is looking to assemble and make more components for other firms, including Google's Pixel smartphones, said the people quoted earlier, speaking on condition of anonymity. “While the early investments in the current tranche will go into expanding its assembly lines, Foxconn in India is looking to expand its presence in the country’s electronics sector beyond catering to the assembly of Apple’s iPhones,” said one of the three people quoted earlier.
This story is from the October 15, 2025 edition of Mint New Delhi.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint New Delhi
Mint New Delhi
India's AI push gets $15 bn Google boost
Move raises Big Tech's total India AI investment plan to $25 bn
2 mins
October 15, 2025
Mint New Delhi
Fresh GST tweaks to wait as govt scans reforms' execution
Central and state governments will retain the current framework of the indirect tax system and maintain the existing goods and services (GST) tax rates as they assess the impact of recent reforms on revenue collection growth before introducing further rate revisions or structural changes such as subsuming petroleum products, according to two people aware of internal discussions.
2 mins
October 15, 2025
Mint New Delhi
Why were sugar exports not so sweet this year?
In January, the central government allowed sugar exports totalling I million tonnes for the 2024-25 season (October-September). However, their shipments fell short of the allotted quota. What went wrong? Mint explains.
2 mins
October 15, 2025
Mint New Delhi
Bira's backers discuss fund infusion tied to CEO's exit
Some large institutional stakeholders in B9 Beverages, maker of Bira 91 beer, have started discussions on the removal of founder and chief executive officer (CEO) Ankur Jain citing his inability to run the financially troubled company, four people aware of the development said.
3 mins
October 15, 2025
Mint New Delhi
Morgan Stanley, MUFG start $1 bn Vena India sale process
GIP to fully exit Vena Energy India as global capital flows into India’s clean energy market
2 mins
October 15, 2025
Mint New Delhi
India needs $217 bn for its nuclear goal
India will require nearly ₹19.3 trillion ($217 billion) of investment to reach its target of installing 100 gigawatts of nuclear power capacity by 2047, according to a power ministry panel’s report, published Tuesday.
1 min
October 15, 2025
Mint New Delhi
How Taylor Swift rewrote the business of record sales
For almost a decade, Adele’s 25 has held the record for first-week album sales with nearly 3.5 million. That mark appeared insurmountable until Taylor Swift released The Life of a Showgirl on Oct. 3. The pop star blew past Adele's total in five days, ultimately earning a hair more than 4-million sales.
4 mins
October 15, 2025
Mint New Delhi
TV old guards bet on short-video boom
As TV suffers a slow decline and audiences rush to dopamine-fuelled shortspan entertainment, makers of hit soap operas that dominated Indian entertainment are turning to microdramas and other short video and audio formats.
2 mins
October 15, 2025
Mint New Delhi
How innovation sustains growth: Mokyr richly deserves his Nobel
Knowledge absorption holds the key and that could depend on a society's openness to ideas and readiness to embrace change
4 mins
October 15, 2025
Mint New Delhi
Roche moves SC against Natco over Risdiplam sale in India
Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug Risdiplam in India.
1 mins
October 15, 2025
Listen
Translate
Change font size